|
|
| Research article summary (published 30 May 2006): |
|
Free Full Text! See links below |
Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases.
Full Abstract
The medical records of 61 dogs with MCT at high risk for metastasis that were treated with prednisone and VBL following excision+/-radiation therapy were reviewed, and median disease-free interval (DFI), median overall survival time (OS) and prognostic factors assessed. Adverse effects, mostly mild, were noted in 26% of patients, usually after the first VBL dose. 6.5% experienced severe neutropenia. The DFI was 1305 days, and the OS was not reached, with 65% alive at 3 years. 100% of dogs with "high-risk" grade II MCT were alive at 3 years. The OS for dogs with grade III MCT was 1374 days. Histologic grade, location (mucous membrane vs. skin) and use of prophylactic nodal irradiation predicted outcome. Prednisone and VBL chemotherapy is well tolerated, and results in good outcomes following surgery in dogs with MCT at high risk for metastasis. High-grade and mucocutaneous tumors had a worse outcome, and the use of prophylactic nodal irradiation appeared to improve outcome in this group of dogs.
Author information
Author/s: Thamm, D H (DH); Turek, M M (MM); Vail, D M (DM);
Affiliation: Department of Clinical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison 53704, USA.
Journal and publication information
Publication Type: Journal Article
Journal: The Journal of veterinary medical science / the Japanese Society of Veterinary Science (J Vet Med Sci), published in Japan. (Language: eng)
Reference: 2006-Jun; vol 68 (issue 6) : pp 581-7
Dates: Created 2006/07/05; Completed 2006/08/22;
PMID: 16820715, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Response of canine mast cell tumors to treatment with oral prednisone.
30 Oct 1994 - Adverse haematological effects of vinblastine, prednisolone and cimetidine treatment: a retrospective study in fourteen dogs with mast cell tumours.
30 Jul 2005 - Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs.
29 Jun 2008 - Use of a reverse saphenous skin flap for the excision of a grade II mast cell tumor on the hind limb of a dog.
30 Jul 2002 - Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997).
30 Aug 1999 - The tyrosine kinase inhibitor imatinib [STI571] induces regression of xenografted canine mast cell tumors in SCID mice.
15 Aug 2006 - Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
30 Dec 2007 - A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors.
26 Feb 2008 - Transferring stereotypes about chemotherapy.
29 Sep 1994 - Clinicopathological features and outcome for dogs with mast cell tumors and bone marrow involvement.
29 Jun 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.